IL-38 Exerts Anti-Inflammatory and Antifibrotic Effects in Thyroid-Associated Ophthalmopathy.
Lu ShiHuijing YeJun HuangYan Bing LiXing WangZhihui XuJingqiao ChenWei XiaoRongxin ChenHuasheng YangPublished in: The Journal of clinical endocrinology and metabolism (2021)
IL-38 plays a protective role in TAO and is associated with its pathogenesis. Our data suggest that IL-38 may be a promising marker of TAO disease activity and a potential target for TAO therapy.